Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression

Nature Medicine

Volumn 4, Issue 5, 1998, Pages 581-587

  Melcher, Alan ^c   Todryk, Stephen ^c   Hardwick, Nicola ^c   Ford, Martin ^a   Jacobson, Michael ^b   Vile, Richard G ^c  

^a GLAXOSMITHKLINE   (United Kingdom)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HEAT SHOCK PROTEIN 70; PROTEIN BCL 2; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL KILLING; COLORECTAL TUMOR; CONTROLLED STUDY; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOSTIMULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; SUICIDE GENE; TUMOR IMMUNOLOGY;

ANIMALS; ANTIGENS, NEOPLASM; ANTIVIRAL AGENTS; APOPTOSIS; CELL DEATH; COLORECTAL NEOPLASMS; GANCICLOVIR; HSP70 HEAT-SHOCK PROTEINS; MELANOMA, EXPERIMENTAL; MICE; NEOPLASMS, EXPERIMENTAL; PROTO-ONCOGENE PROTEINS C-BCL-2; SIMPLEXVIRUS; THYMIDINE KINASE;

ANIMALIA;

EID: 0031836938     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0598-581     Document Type: Article

References (44)

1. Houghton, A.N. Cancer antigens: immune recognition of self and altered self. J. Exp. Med. 180, 1-4 (1994).
2. Hellstrom, K.E., Hellstrom, I. & Chen, L. Can co-stimulated tumor immunity be therapeutically efficacious? Immunol. Rev. 145, 123-145 (1995).
3. Pardoll, D.M. Paracrine Cytokine Adjuvants in Cancer Immunotherapy Ann. Rev. Immunol. 13, 399-415 (1995).
4. Forni, G. et al. Molecular approaches to cancer immunotherapy Cytokin. Mol. Ther. 1, 225-248 (1995).
5. Vile, R.C. & Chong, H. Immunotherapy: Combinatorial molecular immunotherapy - a synthesis and suggestions. Can. Metast. Rev. 15, 351-364 (1996).
6. Cayeux, S., Richter, G., Noffz, G., Dorken, B. & Blankenstein, T. Influence of gene-modified (IL-7, IL-4 and B7) tumor cell cvaccines on tumor antigen presentation. J. Immunol. 158, 2834-2841 (1997).
7. Cavallo, F. et al. Protective and curative potential of vaccination with interleukin-2-gene transfected cells from a spontaneous mouse mammary adenocarcinoma. Cancer Res. 53, 5067-5070 (1993).
8. Freeman, S.M., Ramesh, R. & Marrogi, A.J. Immune system in suicide gene therapy. Lancet 349, 2-3 (1997).
9. Huang, A.Y.C., Bruce, A.T., Pardoll, D.M. & Levitsky, H.I. In vivo cross-priming of MHC Class I-restricted antigens requires a TAP transporter. Immunity 4, 349-355 (1996).
10. Dranoff, G. et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte macrophage colony stimulating factor stimulates potent, specific, and long lasting anti-tumor immunity. Proc. Nat. Acad. Sci. USA 90, 3539-354, (1993).
11. Suto, R. & Srivastava, P.K. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269, 1585-1588 (1995).
12. Tamura, Y., Peng, P., Liu, K., Daou, M. & Srivastava, P.K. Immunotherapy of tumors with autologous tumor-derived heat shock protein preparations. Science 278, 117-120 (1997).
13. Barba, D., Hardin, J., Sadelain, M. & Gage, F.H. Development of anti tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc. Nat. Acad. Sci. USA 91, 4348-4352 (1994).
14. Caruso, M. et al. Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc. Nat. Acad. Sci. USA 90, 7024-7028 (1993).
15. Vile, R.G., Nelson, J.A., Castleden, S., Chong, H. & Hart, I.R. Systemic gene therapy of murine melanoma using tissue specific expression of the HSVtk gene involves an immune component. Cancer Research 54, 6228-6234 (1994).
16. Vile, R.G. et al. Generation of an anti-tumor immune response in a non-immunogenic tumor: HSVtk-killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoral cytokine expression. Intl. J. Cancer 71, 267-274 (1997).
17. Castleden, S.A. et al. A family of bicistronic vectors to enhance both local and systemic anti tumor effects of HSVtk or cytokine expression in a murine melanoma model. Hum. Gene Ther. 8, 2087-2102 (1997).
18. Consalvo, M. et al. 5-fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory. J. Immun. 154, 5302-5312 (1995).
19. Mullen, C.A., Coale, M.M., Lowe, R. & Blaese, R.M. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. Can. Res. 54, 1503-1506 (1994).
20. Colombo, M.P., Modesti, A., Parmiani, G. & Forni, G. Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk. Can. Res. 52, 4853-485 (1992).
21. Huang, A.Y.C. et al. Role of bone marrow derived cells in presenting MHC Class I-restricted tumor antigens. Science 264, 961-965 (1994).
22. Maass, G. et al. Priming of tumor specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: Three consecutive stages may be required for successful tumor vaccination. Proc. Nat. Acad. Sci. USA 92, 5540-5544 (1995).
23. Fuchs, E.J. & Matzinger, P. Is cancer dangerous to the immune system? Sem. Immunol. 8, 271-280 (1996).
24. Matzinger, P. Tolerance, danger and the extended family. Annual Review of Immunol. 12, 991-1045 (1994).
25. Speiser, D.E. et al. Self antigens expressed by solid tumors do not efficiently stimulate naive or activated T cells: Implications for immunotherapy. J. Exp. Med. 186, 645-653 (1997).
26. Castleden, S.A. Combination gene therapies for the immunotherapy of cancer. PhD Thesis, University of London. (1997).
27. Vile, R.G. & Hart, I.R. Use of tissue-specific expression of the Herpes Simplex Virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Can. Res. 53, 3860-3864 (1993).
28. Wyllie, A.H. Apoptosis (The 1992 Frank Rose Memorial Lecture) B. J. Can. 67, 205-208 (1993).
29. Columbano, A. Cell death: current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo. J. Cell. Biochem. 58, 181-190 (1995).
30. Plettenberg, A. et al. Human melanocytes and melanoma cells constitutively express the Bcl-22 protooncogene in situ and in cell culture. Am. J. Path. 146, 651-659 (1995).
31. Jacobson, M.D. Apoptosis: Bcl-2-related proteins get connected. Cur. Biol. 7, R277-R281 (1997).
32. Arends, M.J., Morris, R.G. & Wyllie, A.H. Apoptosis. The role of endonuclease. Am. J. Pathol. 136, 593-608 (1990).
33. Hunt, C. & Calderwood, S. Characterisation and sequence of a mouse hsp70 gene and its expression in mouse cell lines. Gene 87, 199-204 (1990).
34. Perry, M.D., Aujame, L., Shtang, S. & Moran, L. Structure and expression of an inducible HSP70-encoding gene from Mus musculus. Gene 146, 273-278 (1994).
35. Freeman, S.M. et al. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified. Can. Res. 53, 5274-5283 (1993).
36. Kaneko, Y. & Tsukamoto, A. Gene therapy of hepatoma: bystander effects and non-apoptotic cell death induced by thymidine kinase and ganciclovir Can. Let. 96, 105-110 (1995).
37. Udono, H., Levey, D.L. & Srivastava, P.K. Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CDS+ T cells in vivo. Proc. Nat. Acad. Sci. USA 91, 3077-3081 (1994).
38. Li, Z. Priming of T cells by heat shock protein-peptide complexes as the basis of tumor vaccines. Sem. Immunol. 9, 315-322 (1997).
39. Wei, Y.-q. et al. Induction of autologous tumor killing by heat treatment of fresh human tumor cells: Involvement of γσ T cells and heat shock protein 70. Can. Res. 56, 1104-1110 (1996).
40. Multhoff, G. et al. Heat shock protein 72 on tumor cells: A recognition structure for Natural Killer cells. J. Immunol. 158, 4341-4350 (1997).
41. Lukacs, K.V., Lowrie, D.B., Stokes, R.W. & Colston, M.J. Tumor cells transfected with a bacterial heat-shock gene lose tumorigenicity and induce protection against tumors. J. Exp. Med. 178, 343-3 (1993).
42. Lukacs, K.V., Nakakes, A., Atkins, C.J., Lowrie, D.B. & Colston, M.J. In vivo gene therapy of malignant tumors with heat shock protein-65 gene. Gene Ther. 4, 346-350 (1997).
43. Fisher, D.E. Apoptosis in Cancer Therapy: Crossing the Threshold Cell 78, 539-542 (1994).
44. Altman, D.G. Analysis of survival times. In: Practical Statistics for Medical Research 365-395 (1991).